Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
1 This landmark study builds on more than 20 years of research in obesity, a serious chronic disease associated with severe co-morbidities and outcomes
Recently, phase III clinical trials for obesity with efpeglenatide are ongoing
Approval or denial of coverage You can check if your specific insurance plan requires that your healthcare provider submit a prior authorization for Ozempic by reviewing your plans drug formulary
In diabetes care, GLP-1 receptor agonists are often evaluated within a framework that prioritizes prevention of complications such as cardiovascular disease, nephropathy, and retinopathy
US$ 20.43
US$ 24.24
US$ 27.60
US$ 29.95
US$ 24.77
